178 related articles for article (PubMed ID: 31837001)
1. Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.
Guo X; Long J; Chen Z; Shu XO; Xiang YB; Wen W; Zeng C; Gao YT; Cai Q; Zheng W
Int J Cancer; 2020 Apr; 146(8):2175-2181. PubMed ID: 31837001
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W
Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955
[TBL] [Abstract][Full Text] [Related]
7. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
8. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko JM; Ning L; Zhao XK; Chai AWY; Lei LC; Choi SSA; Tao L; Law S; Kwong A; Lee NP; Chan KT; Lo A; Song X; Chen PN; Chang YL; Wang LD; Lung ML
Int J Cancer; 2020 Feb; 146(4):1042-1051. PubMed ID: 31396961
[TBL] [Abstract][Full Text] [Related]
9.
Shimelis H; Mesman RLS; Von Nicolai C; Ehlen A; Guidugli L; Martin C; Calléja FMGR; Meeks H; Hallberg E; Hinton J; Lilyquist J; Hu C; Aalfs CM; Aittomäki K; Andrulis I; Anton-Culver H; Arndt V; Beckmann MW; Benitez J; Bogdanova NV; Bojesen SE; Bolla MK; Borresen-Dale AL; Brauch H; Brennan P; Brenner H; Broeks A; Brouwers B; Brüning T; Burwinkel B; Chang-Claude J; Chenevix-Trench G; Cheng CY; Choi JY; Collée JM; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Dörk T; Dos-Santos-Silva I; Dunning AM; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Glendon G; Guénel P; Haiman CA; Hall P; Hamann U; Hartman M; Hogervorst FB; Hollestelle A; Hopper JL; Ito H; Jakubowska A; Kang D; Kosma VM; Kristensen V; Lai KN; Lambrechts D; Marchand LL; Li J; Lindblom A; Lophatananon A; Lubinski J; Machackova E; Mannermaa A; Margolin S; Marme F; Matsuo K; Miao H; Michailidou K; Milne RL; Muir K; Neuhausen SL; Nevanlinna H; Olson JE; Olswold C; Oosterwijk JJC; Osorio A; Peterlongo P; Peto J; Pharoah PDP; Pylkäs K; Radice P; Rashid MU; Rhenius V; Rudolph A; Sangrajrang S; Sawyer EJ; Schmidt MK; Schoemaker MJ; Seynaeve C; Shah M; Shen CY; Shrubsole M; Shu XO; Slager S; Southey MC; Stram DO; Swerdlow A; Teo SH; Tomlinson I; Torres D; Truong T; van Asperen CJ; van der Kolk LE; Wang Q; Winqvist R; Wu AH; Yu JC; Zheng W; Zheng Y; Leary J; Walker L; Foretova L; Fostira F; Claes KBM; Varesco L; Moghadasi S; Easton DF; Spurdle A; Devilee P; Vrieling H; Monteiro ANA; Goldgar DE; Carreira A; Vreeswijk MPG; Couch FJ; ;
Cancer Res; 2017 Jun; 77(11):2789-2799. PubMed ID: 28283652
[TBL] [Abstract][Full Text] [Related]
10. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.
Zhang Y; Long J; Lu W; Shu XO; Cai Q; Zheng Y; Li C; Li B; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):622-8. PubMed ID: 24470074
[TBL] [Abstract][Full Text] [Related]
11. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
[TBL] [Abstract][Full Text] [Related]
12. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
Wilcox N; Dumont M; González-Neira A; Carvalho S; Joly Beauparlant C; Crotti M; Luccarini C; Soucy P; Dubois S; Nuñez-Torres R; Pita G; Gardner EJ; Dennis J; Alonso MR; Álvarez N; Baynes C; Collin-Deschesnes AC; Desjardins S; Becher H; Behrens S; Bolla MK; Castelao JE; Chang-Claude J; Cornelissen S; Dörk T; Engel C; Gago-Dominguez M; Guénel P; Hadjisavvas A; Hahnen E; Hartman M; Herráez B; ; Jung A; Keeman R; Kiechle M; Li J; Loizidou MA; Lush M; Michailidou K; Panayiotidis MI; Sim X; Teo SH; Tyrer JP; van der Kolk LE; Wahlström C; Wang Q; Perry JRB; Benitez J; Schmidt MK; Schmutzler RK; Pharoah PDP; Droit A; Dunning AM; Kvist A; Devilee P; Easton DF; Simard J
Nat Genet; 2023 Sep; 55(9):1435-1439. PubMed ID: 37592023
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM
Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529
[TBL] [Abstract][Full Text] [Related]
16. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.
Kanaan Y; Kpenu E; Utley K; Adams-Campbell L; Dunston GM; Brody LC; Broome C
Hum Genet; 2003 Oct; 113(5):452-60. PubMed ID: 12942367
[TBL] [Abstract][Full Text] [Related]
17. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
[TBL] [Abstract][Full Text] [Related]
18. Identification of Recurrent Variants in
Jiang Y; Tian T; Yu C; Zhou W; Yang J; Wang Y; Wen Y; Chen J; Dai J; Jin G; Ma H; Shen H; Hu Z
Biomed Res Int; 2020; 2020():6739823. PubMed ID: 32879886
[No Abstract] [Full Text] [Related]
19. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
20. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
